^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
TAK-012
i
Other names: allogeneic Vδ1 γδ T cell therapy, GDX 012, TAK 012, GDX-012, TAK012, TAK-012, GDX012, Allogeneic variable delta 1 gamma-delta T cell cancer therapy
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Takeda
Drug class:
Immunomodulator, γδ TCR modulator
Related drugs:
over1year
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (clinicaltrials.gov)
P1/2, N=53, Not yet recruiting, Takeda
New P1/2 trial
|
cyclophosphamide • TAK-012
Share via
